PubMed Health⌕ Search

Biomedical subjects

W L Gong

Publications and source records attributed to W L Gong.

5 recordsLinked to original sources
PubMed2005

Feasibility of using ultrasonic irradiation to recover active biomass from waste activated sludge.

Under typical operating conditions, the microbial fraction of activated sludge flocs is approximately 40% by weight. The objective of this research is to evaluate the feasibility of using ultrasonic irradiation to disrupt activated sludge flocs allowing for the subsequent separation of active and inactive fractions. If separation of floc components is possible, then methods may be incorporated into wastewater treatment plant operations whereby only the inactive fraction of floc is wasted (i.e., of waste activated sludge, WAS), which in turn could increase the overall effective biological solids retention time, leading to increased process robustness with no net increase in reactor size. The results indicate that ultrasonic irradiation of WAS at 800 Wl(-1) followed by 30 min of settling can produce a supernatant with heterotrophic specific oxygen uptake rates (SOURs) of over two times the SOUR measured in the bulk mixed liquor. Under these conditions 26% of the initial heterotrophic activity was recovered within only 11% of the initial volatile mass. Similarly, autotrophic analysis revealed that nitrifying organisms, while sensitive to the effects of ultrasonic irradiation, can be separated from the activated sludge floc and recovered. An irradiation density of 200 Wl(-1) with an exposure time between 1 and 2 min produced a supernatant with a specific ammonia removal rate of over two times the initial mixed liquor rate.

Bacteria↗
PubMed1994

Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis.

DNA from 36 patients with chronic myelogenous leukemia (CML) at various clinical stages and 6 cases of acute leukemia was investigated for alterations of the p53 gene by Southern blot analysis. Rearrangements of the p53 gene were seen in 3 of 12 (25.00%) cases of blast crisis and accelerated phase (AP) of CML and in only one of 18 chronic phrase (CP), just as has been reported previously. Meanwhile, by restriction fragment length polymorphism (RFLP) analysis the Bgl II site polymorphism in the p53 gene was also found. The frequency in Chinese people detected here was 0.392, which was strikingly higher than that in some other countries (P < 0.001). These results suggested that the alterations of the p53 gene, for example, p53 rearrangements, were probably responsible for the progression of BC in some CML patients, and that the frequency of Bgl II polymorphism in the p53 gene might be related to the population distribution.

Blast Crisis↗
PubMed1991

BCR rearrangements in Ph positive chronic myelocytic leukemia.

Nine patients with chronic myelocytic leukemia (CML) and 1 patient with erythroleukemia were studied with 3'bcr and 5'bcr probes using Southern blot hybridization technique. Bcr rearrangements were detected in 8 patients with CML in the chronic phase, and bcr rearrangement was deduced to have existed in a CML patient in blastic crisis. However, no abnormal fragment was found in the patient with erythroleukemia. 3'bcr and 5'bcr probes combined with proper restriction enzymes were believed to be of great value in determining bcr rearrangements in Ph positive CML.

Adolescent↗
PubMed1990

Cytogenetic study on acute lymphoblastic leukemia.

During 1987-1988 cytogenetic studies were performed in 30 patients with acute lymphoblastic leukemia (ALL). Of the 30 patients 15 (10 children and 5 adults) were found to have abnormal karyotypes including 8 cases (27%) of pseudodiploidy, 2 cases (7%) of hypodiploidy, one case (3%) of low-hyperdiploidy (modal number 47-50), and 4 cases (13%) of high-hyperdiploidy (modal number greater than 50). Immunological classification was performed by using monoclonal antibodies in 26 patients, and the most common immunophenotype was C-ALL. The patients with abnormal karyotypes were more likely to be NuLL-ALL (6 in 14) as compared with patients with normal karyotype (1 in 12). In our series, there was no significant difference between the patients with and without cytogenetic changes in regard of clinical findings such as FAB classification, the rate of complete remission, percentage of lymphoblasts in bone marrow cells and blood picture.

Adolescent↗